MAT2B
Methionine adenosyltransferase 2 subunit beta
Also known as: MAT2B_HUMAN, MATIIbeta, SDR23E1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZL9
- Gene
- MAT2B
- Ensembl
- ENSG00000038274
- Chromosome
- 5
- Canonical length
- 334 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene belongs to the methionine adenosyltransferase (MAT) family. MAT catalyzes the biosynthesis of S-adenosylmethionine from methionine and ATP. This protein is the regulatory beta subunit of MAT. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Nov 2012]
Canonical amino-acid sequenceUniProt
334 residues, UniProt reviewed canonical sequence.
>Q9NZL9|MAT2B
1 MVGREKELSI HFVPGSCRLV EEEVNIPNRR VLVTGATGLL GRAVHKEFQQ NNWHAVGCGF
61 RRARPKFEQV NLLDSNAVHH IIHDFQPHVI VHCAAERRPD VVENQPDAAS QLNVDASGNL
121 AKEAAAVGAF LIYISSDYVF DGTNPPYREE DIPAPLNLYG KTKLDGEKAV LENNLGAAVL
181 RIPILYGEVE KLEESAVTVM FDKVQFSNKS ANMDHWQQRF PTHVKDVATV CRQLAEKRML
241 DPSIKGTFHW SGNEQMTKYE MACAIADAFN LPSSHLRPIT DSPVLGAQRP RNAQLDCSKL
301 ETLGIGQRTP FRIGIKESLW PFLIDKRWRQ TVFHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MAT2B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.26
- Highest tissue expression
- 100 nTPM
Expression across tissuesHPA
Tissue
- kidney: 100 nTPM
- lymph node: 95 nTPM
- tonsil: 87 nTPM
- thymus: 84 nTPM
- spleen: 80 nTPM
- duodenum: 80 nTPM
Single-cell type
- oocytes: 170 nCPM
- parietal cells: 118 nCPM
- kupffer cells: 110 nCPM
- ocular epithelial cells: 75 nCPM
- megakaryocytes: 74 nCPM
- hepatocytes: 72 nCPM
Immune cell
- total PBMC: 707 nTPM
- basophil: 631 nTPM
- T-reg: 541 nTPM
- eosinophil: 483 nTPM
- NK-cell: 406 nTPM
- neutrophil: 366 nTPM
Brain region
- choroid plexus: 46 nTPM
- midbrain: 44 nTPM
- cerebellum: 40 nTPM
- hypothalamus: 40 nTPM
- spinal cord: 40 nTPM
- thalamus: 40 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.68
- gnomAD pLI
- 0.05
- gnomAD missense Z
- 1.07
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- enzyme binding
- enzyme regulator activity
- methionine adenosyltransferase regulator activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- NAD(P)-binding domain superfamily
- dTDP-4-dehydrorhamnose reductase
- RmlD-like, substrate binding domain
- RmlD substrate binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MAT2B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MAT2B as an antibody target. Whether an autoantibody or antibody against MAT2B could matter depends on whether native MAT2B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MAT2B is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MAT2B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...